Maize and Blue Go Pink!


Cancer Center

The Details


To our hosts

Catherine and Nathan Forbes


Dr. Ora Hirsch Pescovitz

University of Michigan Executive Vice President for Medical affairs and CEO of the University of Michigan Health System


Master and Mistress of Ceremonies

Steve and Landyn Hutchinson


Proceeds benefit breast cancer research at The University of Michigan Comprehensive Cancer Center.
For more information contact



Somerset Collection

The Forbes Company




Rock Ventures

Campbell Ewald

The David A. Brandon Foundation

The Eisenberg Family

Stacy and Ron Klein

The Schostak Family

Seattle Genetics

About the Cause


Supporting Breast Cancer Research at the University of Michigan

There has never been a more exciting, promising moment in breast cancer research. The U-M Comprehensive Cancer Center is leading the world in discovering and developing personalized cancer therapies, anchored by its Breast Oncology Program. Perhaps more than any other academic institution in the country, U-M cancer scientists are poised to revolutionize the way breast cancer is treated.

The U-M's multifaceted and revolutionary approach to breast cancer — from molecular-based, personalized therapies to addressing the whole family's quality of life — make this the place for tomorrow's cancer care.

As we stand on the brink of phenomenal advances, greater investment in breast cancer research is needed now.

An investment in the U-M Breast Oncology Program is an unprecedented opportunity to define the future of breast cancer care around the world. The time is now to transform our groundbreaking discoveries into patient care as quickly as possible. The millions of women, families and communities affected by breast cancer should not have to wait.

Join us in creating the future of breast cancer care.

Max Wicha

Max Wicha, M.D.

Director, U-M Comprehensive Cancer Center

Distinguished Professor of Oncology

Daniel Hayes

Daniel F. Hayes, M.D.

Clinical Director, Breast Oncology Program

Stuart B. Padnos Professor of Breast Cancer Research

Sofia Merajver

Sofia Merajver, M.D., Ph.D.

Scientific Director, Breast Oncology Program

Director, Breast and Ovarian Cancer Risk Evaluation Program

Professor of Internal Medicine


Lisa Newman

Lisa Newman, M.D., M.P.H., F.A.C.S

Director, U-M Breast Care Center

Professor of Surgery